ATG16L1 and hepatocellular carcinoma: Therefore, it was predicted that C3G could enhance ATG16L1-mediated autophagy through the circ_0001345/miR-106b/ATG16L1 axis identified via database analysis to achieve therapeutic goals for HCC treatment.